OʻSMIR YOSHDAGI BEMORLARDA YARA KASALLIGINING KLINIK KECHISHIGA OVQATLANISH VA TURMUSH TARZINING TAʼSIRI
Keywords:
aralash taʼsirlar chiziqli modeli, klinik zoʻrayishlar, nosogʻlom turmush tarzi, parhez rejimiAbstract
Oʻsmirlik davrida yara kasalligining zoʻrayishlari parhez rejimi va uyqu tartibi bilan qanday bogʻlanishi klinik amaliyotda yetarlicha aniq tavsiflanmagan; tadqiqotning maqsadi ushbu omillarning klinik kechishdagi oʻrnini baholashdan iborat boʻldi. Kuzatuv asosidagi klinik tadqiqot 12–17 yoshdagi 60 nafar bemorni qamrab oldi: nisbatan sogʻlom ovqatlanish va muntazam turmush tarzi guruhi 30 nafar, notoʻgʻri ovqatlanish va nosogʻlom turmush tarzi guruhi 30 nafar. Ishtirokchilarning 34 nafari (56,7 %) oʻgʻil bolalar, 26 nafari (43,3 %) qizlar edi; oʻrtacha yosh M = 14,5, SD = 1,6, oraliq 12–17 yilni tashkil etdi. Uzunlamasına panel tadqiqoti va aralash taʼsirlar chiziqli modeli yordamida klinik belgilar dinamikasi hamda olti oylik zoʻrayishlar chastotasi tahlil qilindi. Barcha bemorlarda zoʻrayishlar soni M = 1,8, SD = 1,1, oraliq 0–4 marta boʻldi; nosogʻlom guruhda chastota 2,4 marta/6 oyga yetib, nisbiy farq 50 % ni tashkil etdi. Ovqatlanish tartibi uchun β = −0,84, standart xato = 0,19, p = 0,001; uyqu davomiyligi uchun β = −0,57, standart xato = 0,16, p = 0,001; nosogʻlom turmush tarzi uchun β = 1,31, standart xato = 0,28, p = 0,001 qayd etildi. Natijalar parhez, uyqu va dori davosini birlashtirgan individual pediatrik koʻrsatmalarni asoslashga xizmat qiladi. Mazkur hissa oʻsmirlarda klinik kuzatuvni turmush tarzi omillari bilan bogʻlaydigan amaliy modelni taklif etishdan iborat
Downloads
References
1. Malfertheiner P., Chan F.K.L., McColl K.E.L. Peptic ulcer disease // The Lancet. — 2009. — Vol. 374. — № 9699. — P. 1449–1461. — DOI: 10.1016/S0140-6736(09)60938-7.
2. Kliegman R.M., St Geme J.W., Blum N.J. et al. Nelson Textbook of Pediatrics. — Philadelphia: Elsevier, 2020. — 3888 p.
3. Rosenstock S., Jørgensen T., Bonnevie O. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults // Gut. — 2003. — Vol. 52. — № 2. — P. 186–193. — DOI: 10.1136/gut.52.2.186.
4. Levenstein S., Rosenstock S., Jacobsen R.K., Jørgensen T. Psychological stress increases risk for peptic ulcer, regardless of Helicobacter pylori infection or use of nonsteroidal anti-inflammatory drugs // Clinical Gastroenterology and Hepatology. — 2015. — Vol. 13. — № 3. — P. 498–506.e1. — DOI: 10.1016/j.cgh.2014.07.052.
5. Konturek P.C., Brzozowski T., Konturek S.J. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options // Journal of Physiology and Pharmacology. — 2011. — Vol. 62. — № 6. — P. 591–599.
6. Sonnenberg A., Müller A.D. Inverse relation between obesity and the risk for peptic ulcer disease // Annals of Internal Medicine. — 1988. — Vol. 109. — № 5. — P. 389–391. — DOI: 10.7326/0003-4819-109-5-389.
7. Moayyedi P., Axon A.T.R. Gastrointestinal consequences of obesity // Best Practice & Research Clinical Gastroenterology. — 2004. — Vol. 18. — № 6. — P. 945–961. — DOI: 10.1016/j.bpg.2004.06.004.
8. Daugule I., Rowland M. Helicobacter pylori infection in children // Helicobacter. — 2008. — Vol. 13. — Suppl. 1. — P. 41–46. — DOI: 10.1111/j.1523-5378.2008.006 ಸ.
9. Koletzko S., Smith N.L., Goodman K.J. et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children // Journal of Pediatric Gastroenterology and Nutrition. — 2011. — Vol. 53. — № 2. — P. 230–243. — DOI: 10.1097/MPA.0b013e3182227e90.
10. Williams N.L., Koletzko S., Goodman K. et al. Joint ESPGHAN/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents // Journal of Pediatric Gastroenterology and Nutrition. — 2017. — Vol. 64. — № 6. — P. 991–1003
11. Rosen R., Vandenplas Y., Singendonk M. et al. Pediatric gastroesophageal reflux clinical practice guidelines // Journal of Pediatric Gastroenterology and Nutrition. — 2018. — Vol. 66. — № 3. — P. 516–554
12. Hojo M., Miwa H., Nagahara A., Sato N. Psychological stress affecting gastric and intestinal motility: an experimental study using a microtransducer // Journal of Gastroenterology. — 2001. — Vol. 36. — № 9. — P. 603–607. — DOI: 10.1007/s005350170055.
13. Konturek S.J., Konturek P.C., Brzozowski T. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options // Journal of Physiology and Pharmacology. — 2011. — Vol. 62. — № 6. — P. 591–599.
14. Ford A.C., Moayyedi P. Meta-analysis: factors affecting the Helicobacter pylori eradication rate // Alimentary Pharmacology & Therapeutics. — 2003. — Vol. 17. — № 6. — P. 821–833. — DOI: 10.1046/j.1365-2036.2003.01461.x.
15. Malfertheiner P., Megraud F., O'Morain C.A. et al. Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report // Gut. — 2017. — Vol. 66. — № 1. — P. 6–30. — DOI: 10.1136/gutjnl-2016-312288.
16. Sugano K., Tack J., Kuipers E.J. et al. Kyoto global consensus report on Helicobacter pylori gastritis // Gut. — 2015. — Vol. 64. — № 9. — P. 1353–1367. — DOI: 10.1136/gutjnl-2015-309252.
17. Shah S.C., Iyer P.G., Moss S.F. AGA clinical practice update on the diagnosis and management of refractory Helicobacter pylori infection // Gastroenterology. — 2021. — Vol. 160. — № 5. — P. 1831–1841. — DOI: 10.1053/j.gastro.2021.01.230.
18. Malfertheiner P., Megraud F., Rokkas T. et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence Consensus Report // Gut. — 2022. — Vol. 71. — № 9. — P. 1724–1762. — DOI: 10.1136/gutjnl-2022-327745.
19. Graham D.Y., Dore M.P. Helicobacter pylori therapy: a paradigm shift // Helicobacter. — 2016. — Vol. 21. — № 6. — P. 459–466. — DOI: 10.1111/hel.12345.
20. Savoldi A., Carrara E., Graham D.Y. et al. Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions // Gastroenterology. — 2018. — Vol. 155. — № 5. — P. 1372–1382.e17. — DOI: 10.1053/j.gastro.2018.07.007.
21. Megraud F., Coenen S., Versporten A. et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption // Gut. — 2013. — Vol. 62. — № 1. — P. 34–42. — DOI: 10.1136/gutjnl-2012-302254.
22. Hooi J.K.Y., Lai W.Y., Ng W.K. et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis // Gastroenterology. — 2017. — Vol. 153. — № 2. — P. 420–429. — DOI: 10.1053/j.gastro.2017.04.022.
